The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe
Open Access
- 1 June 2000
- journal article
- Published by Wiley in European Journal of Heart Failure
- Vol. 2 (2) , 123-132
- https://doi.org/10.1016/s1388-9842(00)00081-7
Abstract
Background: The EUROHEART programme is a rolling programme of cardiovascular surveys among the member nations of the European Society of Cardiology (ESC). These surveys will provide information on the nature of cardiovascular disease and its management. This manuscript describes a survey into the nature and management of heart failure.Aims: The Euroheart Failure survey aims to describe the quality of hospital care, diagnostic and therapeutic, for patients with suspected or confirmed heart failure in ESC member countries. Patients will be interviewed subsequent to hospital discharge to assess their understanding of their condition, side effects from and their compliance with therapy and their satisfaction with the management for heart failure. The quality of management will be judged against the recommendations contained in the ESC guidelines on diagnosis and treatment of heart failure. Outcome will be further assessed by repeat interviews in 6–12 months time. A further survey of heart failure in 2001/2002 is also planned.Methods: A prospective survey of all deaths and discharges from medical (cardiology, internal medicine and geriatric medicine) and cardiac surgical wards to identify patients with heart failure, suspected or confirmed. Approximately 70 hospital clusters, comprising two to six hospitals in each cluster, in 24 member countries of the ESC are conducting the study. At the time of writing, approximately 30 000 deaths and discharges have been screened and approximately 4000 patients have been enrolled.Conclusions: The Euroheart Survey will allow actual practice to be compared to ESC guidelines on the diagnosis and treatment of heart failure. The surveys and guidelines should prove mutually informative. The main EuroHeart Failure project will be completed by late 2000. However, new centres volunteering to participate in the study (contact corresponding author) may be accepted providing they have the necessary research personnel and provided funding can be agreed for statistical support and administration.Keywords
This publication has 32 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Factors determining angiotensin‐converting enzyme inhibitor underutilization in heart failure in a community settingClinical Cardiology, 1998
- Screening For Left Ventricular Dysfunction and Chronic Heart FailureDisease Management and Health Outcomes, 1997
- Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitalsThe American Journal of Cardiology, 1996
- Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence?QJM: An International Journal of Medicine, 1996
- Evidence of inadequate investigation and treatment of patients with heart failure.Heart, 1994
- Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunctionJournal of the American College of Cardiology, 1994
- Bedside diagnosis of preserved versus impaired left ventricular systolic function in heart failureThe American Journal of Cardiology, 1991
- Epidemiologic aspects of heart failureAmerican Heart Journal, 1990
- A Prospective Study of Elderly General Surgical Patients: I. Pre-operative Medical ProblemsAge and Ageing, 1989